These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Stability of extemporaneously compounded spironolactone suspensions. Mathur LK; Wickman A Am J Hosp Pharm; 1989 Oct; 46(10):2040-2. PubMed ID: 2816959 [TBL] [Abstract][Full Text] [Related]
46. Stability of extemporaneously prepared rufinamide oral suspensions. Hutchinson DJ; Liou Y; Best R; Zhao F Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505 [TBL] [Abstract][Full Text] [Related]
47. Stability of an extemporaneously prepared tadalafil suspension. Pettit RS; Johnson CE; Caruthers RL Am J Health Syst Pharm; 2012 Apr; 69(7):592-4. PubMed ID: 22441791 [TBL] [Abstract][Full Text] [Related]
48. Stability of nifedipine in two oral suspensions stored at two temperatures. Nahata MC; Morosco RS; Willhite EA J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010 [TBL] [Abstract][Full Text] [Related]
49. Stability of an extemporaneously prepared clopidogrel oral suspension. Skillman KL; Caruthers RL; Johnson CE Am J Health Syst Pharm; 2010 Apr; 67(7):559-61. PubMed ID: 20237383 [TBL] [Abstract][Full Text] [Related]
50. Beyond-use dating of lidocaine alone and in two "magic mouthwash" preparations. Kirk LM; Brown SD; Luu Y; Ogle A; Huffman J; Lewis PO Am J Health Syst Pharm; 2017 May; 74(9):e202-e210. PubMed ID: 28438825 [TBL] [Abstract][Full Text] [Related]
51. Stability of zonisamide in extemporaneously compounded oral suspensions. Abobo CV; Wei B; Liang D Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126 [TBL] [Abstract][Full Text] [Related]
52. Stability of gabapentin in extemporaneously compounded oral suspensions. Friciu M; Roullin VG; Leclair G PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771 [TBL] [Abstract][Full Text] [Related]
53. Stability of an extemporaneously compounded minoxidil oral suspension. Song Y; Chin ZW; Ellis D; Lwin EMP; Turner S; Williams D; Garg S Am J Health Syst Pharm; 2018 Mar; 75(5):309-315. PubMed ID: 29472513 [TBL] [Abstract][Full Text] [Related]
54. Stability of sulfadiazine oral liquids prepared from tablets and powder. Pathmanathan U; Halgrain D; Chiadmi F; Schlatter J; Vermerie N J Pharm Pharm Sci; 2004 Apr; 7(1):84-7. PubMed ID: 15144740 [TBL] [Abstract][Full Text] [Related]
55. Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension. Manchanda A; Laracy M; Savji T; Bogner RH Int J Pharm Compd; 2018; 22(1):66-75. PubMed ID: 29385387 [TBL] [Abstract][Full Text] [Related]
56. Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension. Atkins JR; Lull ME; Decker AS; Hutchinson DJ Int J Pharm Compd; 2018; 22(4):326-328. PubMed ID: 30021187 [TBL] [Abstract][Full Text] [Related]
57. Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases. Teimouri A; Yeung P; Agu RU Int J Pharm Compd; 2021; 25(4):344-351. PubMed ID: 34297697 [TBL] [Abstract][Full Text] [Related]
58. Enteral suspension of nifedipine for neonates. Part 1. Formulation of nifedipine suspension for hospital use. Helin-Tanninen M; Naaranlahti T; Kontra K; Wallenius K J Clin Pharm Ther; 2001 Feb; 26(1):49-57. PubMed ID: 11286607 [TBL] [Abstract][Full Text] [Related]
59. Stability of pentoxifylline in an extemporaneously prepared oral suspension. Abdel-Rahman S; Nahata MC Am J Health Syst Pharm; 1997 Jun; 54(11):1301-3. PubMed ID: 9179352 [TBL] [Abstract][Full Text] [Related]
60. Physicochemical and Microbiological Stability of Compounded Bethanechol Chloride Oral Suspensions in PCCA Base, SuspendIt®. Pramar YV; Davis C; Ip K; Banov D Int J Pharm Compd; 2024; 28(4):321-328. PubMed ID: 39094044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]